PP_1170x120_10-25-21

cancer

AllianceRx Walgreens Prime studies the use of cyclin-dependent kinase 4/6 inhibitors in breast cancer patients

AllianceRx Walgreens Prime studies the use of cyclin-dependent kinase 4/6 inhibitors in breast cancer patients

ORLANDO, Fla. —A recent study of metastatic breast cancer (MBC) patients, prescribed a class of drugs that interrupt malignant cell growth, revealed high rates of adherence, low side effects and low rates of patients stopping their medication. The class of drugs is known as cyclin-dependent kinase (CDK) 4/6 inhibitors. The retrospective study was conducted by AllianceRx

Walgreens launches cancer patient support program

Walgreens launches cancer patient support program

DEERFIELD, Ill. — Walgreens Monday launched “Feel More Like You,” a first-of-its-kind pharmacy, health and beauty service available at no cost to help people living with cancer manage the medical and physical changes associated with cancer treatment. The retailer created Feel More Like You to meet the increasing needs of people impacted by cancer to

Adheris Health